GlucoTrack Stock (NASDAQ:GCTK)


OwnershipFinancialsChart

Previous Close

$0.40

52W Range

$0.29 - $15.90

50D Avg

$0.69

200D Avg

$3.45

Market Cap

$232.66K

Avg Vol (3M)

$4.89M

Beta

0.67

Div Yield

-

GCTK Company Profile


Based in Or Yehuda, Israel, GlucoTrack, Inc. is a medical technology company focused on innovating, developing, and bringing to market non-invasive glucose monitoring systems. Their primary offering, the GlucoTrack device, enables individuals with diabetes or pre-diabetes to painlessly check their blood glucose levels. This technology is available to customers both in Israel and across the globe. The company, founded in 2001, operated under the name Integrity Applications, Inc. until it officially rebranded to GlucoTrack, Inc. in November 2021.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

IL

Employees

11

IPO Date

Apr 25, 2013

Website

GCTK Performance


GCTK Financial Summary


Dec 25Dec 24Dec 23
Revenue---
Operating Income-$-14.55M$-7.10M
Net Income-$-22.60M$-7.10M
EBITDA-$-21.98M$-7.08M
Basic EPS-$60.76$-38.30
Diluted EPS-$60.76$-38.30

Fiscal year ends in Dec 25 | Currency in USD

Peer Comparison


TickerCompany
AKANAkanda Corp.
BGMSBio Green Med Solution, Inc.
VEROVenus Concept Inc.
NAOVNanoVibronix, Inc.
INMInMed Pharmaceuticals Inc.
BBLGBone Biologics Corporation
NDRAENDRA Life Sciences Inc.
RDHLRedHill Biopharma Ltd.
DHAIDIH Holding US, Inc.
HSCSHeartSciences Inc.